Reported 10 months ago
Cassava Sciences has appointed Richard Barry as Executive Chairman and principal executive officer following the resignation of CEO Remi Barbier. The company is now in search of a permanent CEO while focusing on maintaining transparency and scientific rigor in its ongoing Alzheimer's trials. This includes adhering to strict FDA protocols and ensuring open communication with stakeholders.
Source: YAHOO